Ben Hale

@benhale.bsky.social

Professor of Medical Virology, University of Zurich, Switzerland. My research group studies molecular mechanisms of the interferon system, interferon deficiencies, and viral disease.

Nice to see that our own Institute of Medical Virology @virology.uzh.ch could contribute to the first genetic sequencing of the Andes hantavirus strain from the ongoing cruise ship outbreak. @med.uzh.ch @uzh-ch.bsky.social

Nick Loman@pathogenomenick.bsky.social · 3mo ago

First genome sequence from Andes hantavirus strain from ongoing ship outbreak posted on Virological: virological.org/t/complete-s... courtesy Swiss National Reference Centre for Emerging Viral Infections, Geneva University Hospitals, University of Zurich

Pleased to have contributed to this work by providing samples from the Swiss HIV Cohort Study - a powerful longitudinal biobank that has been running for almost 40 years & which is an amazing resource for studying both HIV pathogenesis & many other aspects of aging biology in human health & disease

Casanova Lab@casanovalab.bsky.social · 3mo ago

1/ We are thrilled to share our collaborative study of B cells producing auto-Abs neutralizing type I IFNs in @cellpress.bsky.social (www.cell.com/cell/abstrac... ).

How does fever work? Our new Science paper shows how elevated body temperature can protect against severe influenza and that avian-origin viruses escape this defence. This is likely one reason why bird flus and some pandemic influenzas can be so severe.🧵 www.science.org/doi/10.1126/...

Avian-origin influenza A viruses tolerate elevated pyrexic temperatures in mammals

Host body temperature can define a virus’s replicative profile—influenza A viruses (IAVs) adapted to 40° to 42°C in birds are less temperature sensitive in vitro compared with human isolates adapted t...

science.org

I very much enjoyed my time in St Andrews, Scotland as a PhD student. If I was still considered an Early-Career Researcher just starting my own laboratory (in my head, I am!), I would certainly be interested in this fellowship opportunity...

Uli Schwarz-Linek@ulischwarzlinek.bsky.social · 9mo ago

Are you an ECR considering a #fellowship as the next step? We are holding a competitive fellowship day in January 2026. Our priority areas: host-pathogen interactions, synthetic biology, enzymology, systems biology, chemical biology. #ScienceCareers biology.st-andrews.ac.uk/news/2025/11...

Thank-you @casanovalab.bsky.social for the kind invitation to be a participant at your celebratory Novo Nordisk Prize Symposium. I appreciated being able to present alongside a great array of leading researchers, & to meet so many welcoming people in the field of Inborn Errors of Immunity! Congrats!

Casanova Lab@casanovalab.bsky.social · 10mo ago

1/ We are celebrating the Novo Nordisk Prize Symposium: Inborn Errors of Immunity – a huge success yesterday at the @institutimagine.bsky.social in Paris featuring talks by 19 leading European researchers on human IEI

'TRIM28 is a target for paramyxovirus V proteins'. Work led by Gauthier Lieber seeks to address whether host activation of endogenous retroelements contributes to antiviral defences. In support of this idea, he describes a viral mechanism that might limit this host response. doi.org/10.1371/jour...

TRIM28 is a target for paramyxovirus V proteins

Author summary Host recognition of viral nucleic acids is fundamental for stimulating antiviral immunity. To prevent aberrant immune activation, cells must precisely differentiate “non-self” from “sel...

doi.org

A nice photo from last week’s ’Celebration of 50 years of Virology’ in St Andrews - marking a milestone in the distinguished career of Rick Randall - a great virologist, colleague and friend - congratulations Rick!

Bild

Interferon research has a long history at the University of Zurich, Switzerland. Charles Weissmann, Professor of Molecular Biology, led the group that first cloned interferon genes. This allowed large-scale production and facilitated the medical use of interferon. @uzh-ch.bsky.social

1981 / 1986 News@40yearsago.bsky.social · last yr.

[January 16th, 1980] Scientists at Biogen have successfully produced human interferon, a natural virus fighter, in a laboratory using gene-splicing techniques, potentially making it a more affordable treatment for various viral infections and cancers. #history #1980s

In our most recent work, Kevin Groen from the lab made AIR cells for rapid & sensitive functional detection of interferon types I, II & III. AIR cells can be used with a live cell luciferase substrate, are highly sensitive & can detect autoantibodies neutralising interferons. doi.org/10.1002/eji....

Highly sensitive reporter cell line for detection of interferon types I–III and their neutralization by antibodies

Interferons (IFNs) are a critical component of innate immune defenses and limit viral disease severity. To advance studies on IFNs and their neutralization by pathogenic autoantibodies, we generated ...

doi.org